» Articles » PMID: 35328241

Radiological Findings Increased the Successful of COVID-19 Diagnosis in Hospitalized Patients Suspected of Respiratory Viral Infection but with a Negative First SARS-CoV-2 RT-PCR Result

Abstract

SARS-CoV-2 is the etiological agent of COVID-19 and may evolve from asymptomatic disease to fatal outcomes. Real-time reverse-transcription polymerase chain reaction (RT-PCR) screening is the gold standard to diagnose severe accurate respiratory syndrome coronavirus 2 (SARS-CoV-2) infection, but this test is not 100% accurate, as false negatives can occur. We aimed to evaluate the potential false-negative results in hospitalized patients suspected of viral respiratory disease but with a negative previous SARS-CoV-2 RT-PCR and analyze variables that may increase the success of COVID-19 diagnosis in this group of patients. A total of 55 hospitalized patients suspected of viral respiratory disease but with a previous negative RT-PCR result for SARS-CoV-2 were included. All the participants had clinical findings related to COVID-19 and underwent a second SARS-CoV-2 RT-PCR. Chest-computed axial tomography (CT) was used as an auxiliary tool for COVID-19 diagnosis. After the second test, 36 patients (65.5%) were positive for SARS-CoV-2 (COVID-19 group), and 19 patients (34.5%) were negative (controls). There were differences between the groups in the platelet count and the levels of D-dimer, procalcitonin, and glucose (p < 0.05). Chest CT scans categorized as COVID-19 Reporting and Data System 5 (CO-RADS 5) were more frequent in the COVID-19 group than in the control group (91.7% vs. 52.6%; p = 0.003). CO-RADS 5 remained an independent predictor of COVID-19 diagnosis in a second SARS-CoV-2 screening (p = 0.013; odds ratio = 7.0, 95% confidence interval 1.5−32.7). In conclusion, chest CT classified as CO-RADS 5 was an independent predictor of a positive second SARS-CoV-2 RT-PCR, increasing the odds of COVID-19 diagnosis by seven times. Based on our results, in hospitalized patients with a chest CT classified as CO-RADS 5, a second SARS-CoV-2 RT-PCR test should be mandatory when the first one is negative. This approach could increase SARS-CoV-2 detection up to 65% and could allow for isolation and treatment, thus improving the patient outcome and avoiding further contagion.

Citing Articles

[Comment on article "Risk factors at admission associated with intubation in patients with COVID-19"].

Lopez-Taboada J Rev Med Inst Mex Seguro Soc. 2023; 61(6):717-718.

PMID: 37995197 PMC: 10712928. DOI: 10.5281/zenodo.10064243.


Diagnostic performance of standardized typical CT findings for COVID-19: a systematic review and meta-analysis.

Nam B, Hong H, Yoon S Insights Imaging. 2023; 14(1):96.

PMID: 37222857 PMC: 10206568. DOI: 10.1186/s13244-023-01429-2.

References
1.
Lippi G, Simundic A, Plebani M . Potential preanalytical and analytical vulnerabilities in the laboratory diagnosis of coronavirus disease 2019 (COVID-19). Clin Chem Lab Med. 2020; 58(7):1070-1076. DOI: 10.1515/cclm-2020-0285. View

2.
Martinez-Fierro M, Diaz-Lozano M, Alvarez-Zuniga C, Ramirez-Hernandez L, Araujo-Espino R, Trejo-Ortiz P . Population-Based COVID-19 Screening in Mexico: Assessment of Symptoms and Their Weighting in Predicting SARS-CoV-2 Infection. Medicina (Kaunas). 2021; 57(4). PMC: 8068236. DOI: 10.3390/medicina57040363. View

3.
Wong H, Lam H, Ho-Tung Fong A, Leung S, Chin T, Lo C . Frequency and Distribution of Chest Radiographic Findings in Patients Positive for COVID-19. Radiology. 2020; 296(2):E72-E78. PMC: 7233401. DOI: 10.1148/radiol.2020201160. View

4.
Guan W, Ni Z, Hu Y, Liang W, Ou C, He J . Clinical Characteristics of Coronavirus Disease 2019 in China. N Engl J Med. 2020; 382(18):1708-1720. PMC: 7092819. DOI: 10.1056/NEJMoa2002032. View

5.
Lazzaroni M, Piantoni S, Masneri S, Garrafa E, Martini G, Tincani A . Coagulation dysfunction in COVID-19: The interplay between inflammation, viral infection and the coagulation system. Blood Rev. 2020; 46:100745. PMC: 7444609. DOI: 10.1016/j.blre.2020.100745. View